Michael Svatoň
Impact in
-
- Immunodeficiency and Autoimmune Disorders
- Immune Cell Function and Interaction
-
- Chronic Lymphocytic Leukemia Research
- Blood disorders and treatments
Papers in
-
- Lymphoma Diagnosis and Treatment 8
- Oncology 6
- Viral-associated cancers and disorders 3
- CAR-T cell therapy research 2
- Co-authors
- Eva Froňková (16 shared papers)Tomáš Kalina (4 shared papers)Anna Šedivá (5 shared papers)Tomáš Milota (4 shared papers)Zuzana Paračková (4 shared papers)Adam Klocperk (4 shared papers)Veronika Kanderová (4 shared papers)Markéta Bloomfield (3 shared papers)
- Journals
- HemaSphere (2 papers)Blood (2 papers)Frontiers in Immunology (2 papers)Cancers (2 papers)Journal of Clinical Immunology (2 papers)
- Partner nations
- CzechiaGermanyNetherlands
In The Last Decade
Michael Svatoň
22 papers receiving 338 citations
Peers
Comparison fields: 5 of 47
- Immunology 127
- Genetics 58
- Pathology and Forensic Medicine 84
- Hematology 45
- Transplantation 9
Countries citing papers authored by Michael Svatoň
This map shows the geographic impact of Michael Svatoň's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Svatoň with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Svatoň more than expected).
Fields of papers citing papers by Michael Svatoň
This network shows the impact of papers produced by Michael Svatoň. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Svatoň. The network helps show where Michael Svatoň may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Svatoň, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 63 | |
| 2 | 2018 | 57 | |
| 3 | 2019 | 39 | |
| 4 | 2020 | 30 | |
| 5 | 2014 | 25 | |
| 6 | 2022 | 24 | |
| 7 | 2019 | 20 | |
| 8 | 2019 | 18 | |
| 9 | 2023 | 13 | |
| 10 | 2019 | 12 | |
| 11 | 2020 | 10 | |
| 12 | 2019 | 6 | |
| 13 | 2024 | 5 | |
| 14 | 2022 | 5 | |
| 15 | 2024 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2021 | 2 | |
| 18 | 2024 | 2 | |
| 19 | Significant Prevalence of Severe Monogenic Immune Defects Among Children with Type 1 Diabetes and Low T1D-Genetic Risk Score | 2018 | 1 |
| 20 | 2025 | 1 |
About Michael Svatoň
Michael Svatoň is a scholar working on Pathology and Forensic Medicine, Oncology, Molecular Biology, Immunology and Public Health, Environmental and Occupational Health, having authored 23 papers that have together received 340 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Cancer Genomics and Diagnostics (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Viral-associated cancers and disorders (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Diabetes and associated disorders (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Immunology (127 citations), Genetics (58 citations), Pathology and Forensic Medicine (84 citations), Hematology (45 citations) and Transplantation (9 citations). Michael Svatoň has collaborated with scholars based in Czechia, Germany and Netherlands. Frequent co-authors include Eva Froňková, Tomáš Kalina, Anna Šedivá, Tomáš Milota, Zuzana Paračková, Adam Klocperk, Veronika Kanderová, Markéta Bloomfield, Zuzana Zemanová and Marek Trněný. Their work appears in journals such as HemaSphere, Blood, Frontiers in Immunology, Cancers and Journal of Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.